Andrés Lanzós
Andrés Lanzós
Data Scientist at Biognosys
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening
R Esposito, N Bosch, A Lanzós, T Polidori, C Pulido-Quetglas, R Johnson
Cancer cell 35 (4), 545-557, 2019
Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features
A Lanzós, J Carlevaro-Fita, L Mularoni, F Reverter, E Palumbo, R Guigó, ...
Scientific Reports. 2017; 7: 41544, 2017
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
J Carlevaro-Fita, A Lanzós, L Feuerbach, C Hong, D Mas-Ponte, ...
Communications Biology 3 (1), 1-16, 2020
EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy
A Lanzós, K Elliott
The FEBS journal, 2019
Protein signature associated with response and progression free survival in late-stage NSCLC patients treated with anti-PD-1 blockade
E Romano, K Sklodowski, V Dozio, A Lanzós, K Beeler
Annals of Oncology 32, S12, 2021
Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients
K Sklodowski, V Dozio, S Lopez-Lastra, A Lanzós, K Beeler, E Romano
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs
A Vancura, A Lanzós, N Bosch, M Torres, AH Gutierrez, S Haefliger, ...
bioRxiv, 2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–8